KOL KNOCKOUT™: Medical Retina Edition | Competing for the Best Outcomes in Retina Round 2

Evolve Image
Media formats available:
Details
Presenters
  • Overview

    This popular CME program is a fun and exciting game show-style quiz competition that features key opinion leaders (KOLs) as contestants. 

    Hosted by Program Chair Sunil K. Srivastava, MD, the final round features Durga Borkar, MD, MMCi (Round 1 winner), battling it out with two new KOL contestants, Hong-Uyen Hua, MD, and Abdul-Hadi Kaakour, MD, MS. The KOLs weigh in on their preferred treatment approach to various challenging case studies presented by Dr. Srivastava. 

    There will be learning, laughter, and only one KOL left standing!

    This content was captured during a live symposium. Voting took place during the symposium. 

  • Target Audience

    This certified continuing medical education activity is designed for retina specialists and comprehensive ophthalmologists involved in the care of patients with retinal diseases.

  • Grantor Statement

    This activity is supported by an independent educational grant from Regeneron Pharmaceuticals, Inc.

  • Learning Objectives

    Upon completion of this activity, the participant should be able to:

    • Evaluate evidence-based management strategies for neovascular age-related macular degeneration
    • Evaluate evidence-based management strategies for diabetic retinopathy/diabetic macular edema
    • Evaluate evidence-based management strategies for retinal vein occlusion
    • Examine the role of different imaging modalities in enhancing diagnostic precision and treatment planning for complex retinal pathologies
  • Accreditation and Credit Designation Statements

    Provided by Evolve Medical Education

     

    Evolve is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
    Evolve designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • Faculty

    Sunil Srivastava, MD
    Surgical Retina Fellowship Director
    Cleveland Clinic Cole Eye Institute
    Cleveland, OH

    Durga Borkar, MD, MMCi 
    Associate Professor of Ophthalmology
    Associate Professor in Population Health Sciences
    Director of Clinical Data Science
    Duke University Eye Center
    Durham, NC

    Hong-Uyen Hua, MD
    Assistant Professor of Ophthalmology  
    Pediatric & Adult Retina Specialist
    University of Miami Miller School of Medicine  
    Bascom Palmer Eye Institute  
    Miami, FL

    Abdul-Hadi Kaakour, MD, MS 
    Vitreoretinal Medicine and Surgery 
    Assistant Professor of Clinical Ophthalmology & Visual Sciences 
    Vanderbilt Eye Institute
    Nashville, TN

  • Disclosure of Relevant Financial Relationships

    DISCLOSURE POLICY

    It is the policy of Evolve that faculty and other individuals  who are in the position to control the content of this activity disclose any real or apparent financial relationships relating to the topics of this educational activity. Evolve has full policies in place that will identify and mitigate all financial relationships prior to this educational activity.
    The following faculty/staff members have the following financial relationships with ineligible companies.

    Durga Borkar, MD, MMCi, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Alimera Sciences, Apellis Pharmaceuticals, Astellas, EyePoint Pharmaceuticals, Genentech, Glaukos, ONL Therapeutics, and Regeneron.

    Hong-Uyen Hua, MD, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant:AbbVie/Allergan, Alcon, Alimera Sciences/ANI, and Genentech.

    Abdul-Hadi Kaakour, MD, MS, has had no financial relationships or affiliations with ineligible companies.

    Sunil K. Srivastava, MD, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Adverum Biotechnologies, Bausch + Lomb, Carl Zeiss Meditec, EyePoint Pharmaceuticals, jCyte, and Regeneron. Grant/Research Support: Alimera Sciences, EyePoint Pharmaceuticals, and Regeneron.

    The Evolve staff, planners and peer reviewer have no financial relationships with ineligible companies.

  • Publication Dates

    Release Date:

    Expiration Date:

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Register

We're glad to see you're enjoying Eye Health Academy…
but how about a more personalized experience?

Register for free